Abstract:
Sound attenuation devices are provided that may be temporarily worn in a person's ear. The devices generally include a first flange that is configured to be disposed in a person's ear; a second flange that is positioned proximate to the first flange and is also configured to be disposed in the person's ear (with the second flange having a proximate end that exhibits an oblong perimeter); and a cylindrical shaft extending from an interior portion of the second flange. The shaft includes an integrally connected pull tab; it extends beyond the proximate end of the second flange; and the shaft includes an integrally formed reinforcing member that spans an exterior side of the shaft and at least a portion of the pull tab. The devices further include a sound filter disposed within an internal cavity of the shaft.
Abstract:
A notification system comprises a plurality of claim checks and a plurality of communication device identifiers. The notification system further comprises a messaging module that is configured to receive an electronic notification of an event. The messaging module is further configured to associate at least one of the claim checks and one of the communication device identifiers with the event. The messaging module is also configured to generate a message that contains the associated claim check and transmit the message to a communications device identified by the communication device identifier. In one embodiment, the notification system further comprises a retrieval module that is responsive to a request to access the event. In another embodiment, the messaging module is configured to receive an electronic notification of a second event and associate the claim check and another communication device identifier with the message.
Abstract:
A new and distinctive variety of a coastal redwood tree designated as “Semper 95.” Semper 95 is distinguished by high tolerance to both low and high temperature, excellent stem straightness, and very fast growth.
Abstract translation:一个被称为“Semper 95”的沿海红木树的新鲜而独特的品种。 Semper 95的特点是耐低温和高温,优良的茎直线性和非常快速的生长。
Abstract:
The present invention relates to methods for developing embryos and producing germination-competent embryos using a liquid embryo development media.
Abstract:
A method and system for providing remote user access to secure financial applications by deployment of SSO software (126) to client workstations (120), including receiving a password for collaborating access to a secure server (110); navigating to the secure server (110) using a web browser (124) on a remote workstation (120); providing user authorisation details and the received password to the secure server (120); generating a subsequent password at the secure server (110) upon validation of the user authorisation details and received password; downloading an SSO deployment file (122) to the remote workstation (120), said deployment file (122) including the subsequent password; executing the SSO deployment file (122) to install an SSO client application (126) on the remote workstation; reading workstation settings and user credentials from a secure file or data store; and running the SSO client application (126) on the workstation to employ the user credentials and subsequent password to logon to the secure application.
Abstract:
A low-profile multilayer cushion assembly which can be used to support the human body under various conditions. The cushion assembly generally includes a top layer of supportive material having a relatively high compression modulus, a middle layer of woven material, and a bottom layer. The bottom layer includes a matrix of supportive material having a relatively low compression modulus and an arrangement of inserts spread throughout the matrix having a relatively high compression modulus. In the preferred embodiment closed-cell polyurethane foam is used for the top layer and inserts, and open-cell polyurethane foam is used for the bottom layer matrix. The inserts are adhesively attached to the matrix to provide additional resistance to buckling. An optional protective cover encases the bottom layer, middle layer, and top layer.
Abstract:
A system and method for integrating point of sale (POS) data with electronic article surveillance (EAS) data, comprising a general-purpose computer for receiving and processing POS and EAS data is disclosed. The system and method preferable comprise reporting analyzed and collated data to a user.
Abstract:
A video-based human, non-human, and/or motion verification system and method may include a video sensor adapted to obtain video and produce video output. The video sensor may include a video camera. The video-based human verification system may further include a processor adapted to process video to verify a human presence, a non-human presence, and/or motion. An alarm processing device may be coupled to the video sensor, the alarm processing device being adapted to receive video output or alert information from the video sensor.
Abstract:
This invention relates to a 24 hour extended release dosage formulation and unit dosage form thereof of venlafaxine hydrochloride, an antidepressant, which provides better control of blood plasma levels than conventional tablet formulations which must be administered two or more times a day and further provides a lower incidence of nausea and vomiting than the conventional tablets. More particularly, the invention comprises an extended release formulation of venlafaxine hydrochloride comprising a therapeutically effective amount of venlafaxine hydrochloride in spheroids comprised of venlafaxine hydrochloride, microcrystalline cellulose and, optionally, hydroxypropylmethylcellulose coated with a mixture of ethyl cellulose and hydroxypropylmethylcellulose.
Abstract:
This invention relates to a 24 hour extended release dosage formulation and unit dosage form thereof of venlafaxine hydrochloride, an antidepressant, which provides better control of blood plasma levels than conventional tablet formulations which must be administered two or more times a day and further provides a lower incidence of nausea and vomiting than the conventional tablets. More particularly, the invention comprises an extended release formulation of venlafaxine hydrochloride comprising a therapeutically effective amount of venlafaxine hydrochloride in spheroids comprised of venlafaxine hydrochloride, microcrystalline cellulose and, optionally, hydroxypropylmethylcellulose coated with a mixture of ethyl cellulose and hydroxypropylmethylcellulose.